Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCordeiro dos Santos, Natasha
dc.contributor.authorMiravitlles Fernández, Marc
dc.contributor.authorCamelier, Aquiles
dc.contributor.authorDurier Cavalcanti de Almeida, Victor
dc.contributor.authorRodrigues Bandeira Tosta Maciel, Roberto
dc.contributor.authorWarken Rosa Camelier, Fernanda
dc.date.accessioned2022-09-07T12:19:30Z
dc.date.available2022-09-07T12:19:30Z
dc.date.issued2022-07
dc.identifier.citationSantos NCD, Miravitlles M, Camelier AA, Almeida VDC, Maciel RRBT, Camelier FWR. Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberc Respir Dis (Seoul). 2022 Jul;85(3):205–20.
dc.identifier.issn2005-6184
dc.identifier.urihttp://hdl.handle.net/11351/8058
dc.descriptionCOPD; Comorbidity; Mortality
dc.description.abstractThis study aimed to describe the prevalence of comorbidities associated with chronic obstructive pulmonary disease (COPD) and their relation with relevant outcomes. A systematic review based on the PRISMA methodology was performed from January 2020 until July 2021. The MEDLINE, Lilacs, and Scielo databases were searched to identify studies related to COPD and its comorbidities. Observational studies on the prevalence of comorbidities in COPD patients and costs with health estimates, reduced quality of life, and mortality were included. Studies that were restricted to one or more COPD pain assessments and only specific comorbidities such as osteoporosis, bronchitis, and asthma were excluded. The initial search identified 1,409 studies and after applying the inclusion and exclusion criteria, 20 studies were finally selected for analysis (comprising data from 447,459 COPD subjects). The most frequent COPD comorbidities were: hypertension (range, 17%-64.7%), coronary artery disease (19.9%-47.8%), diabetes (10.2%-45%), osteoarthritis (18%-43.8%), psychiatric conditions (12.1%-33%), and asthma (14.7%-32.5%). Several comorbidities had an impact on the frequency and severity of COPD exacerbations, quality of life, and mortality risk, in particular malignancies, coronary artery disease, chronic heart failure, and cardiac arrhythmias. Comorbidities, especially cardiovascular diseases and diabetes, are frequent in COPD patients, and some of them are associated with higher mortality.
dc.language.isoeng
dc.publisherKorean Academy of Tuberculosis and Respiratory Diseases
dc.relation.ispartofseriesTuberculosis and Respiratory Diseases;85(3)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectPulmons - Malalties obstructives - Complicacions
dc.subjectComorbiditat
dc.subjectHipertensió
dc.subject.meshComorbidity
dc.subject.meshPulmonary Disease, Chronic Obstructive
dc.subject.mesh/complications
dc.subject.meshHypertension
dc.titlePrevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.4046/trd.2021.0179
dc.subject.decscomorbilidad
dc.subject.decsenfermedad pulmonar obstructiva crónica
dc.subject.decs/complicaciones
dc.subject.decshipertensión
dc.relation.publishversionhttps://doi.org/10.4046/trd.2021.0179
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Santos NCD, Camelier AA, Almeida VDC, Maciel RRBT, Camelier FWR] Department of Life Sciences, State University of Bahia (UNEB), Bahia, Brazil. [Miravitlles M] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
dc.identifier.pmid35618259
dc.identifier.wos000821996300001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record